Western States Network for Improving Addiction Care
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
Trying new medications, counseling, telehealth, and peer outreach to help people who use drugs start and stay in treatment and reduce harm.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-11261245 on NIH RePORTER |
What this research studies
This regional research network runs clinical trials and outreach programs across hospitals, VA sites, community clinics, and peer organizations in the Western U.S. They test medications (including buprenorphine), behavioral therapies, telehealth services, and peer-led harm reduction to close gaps in the addiction care pathway. Projects enroll people who use drugs, including those not currently in treatment, and may include medication, counseling visits, surveys, or biospecimen collection. People with lived experience are involved in designing the work to make procedures more practical and respectful for participants.
Who could benefit from this research
Good fit: Adults who use opioids or other drugs—including patients in VA care, community opioid treatment programs, telehealth clinics, or reached by peer outreach in the Western U.S.—are typical candidates.
Not a fit: People without a substance use disorder or those outside the participating regions or care settings are unlikely to benefit directly from this network's studies.
Why it matters
Potential benefit: If successful, the work could make it easier to begin and remain on effective addiction treatment, lower overdose risk, and improve overall health and stability.
How similar studies have performed: Previous CTN trials have successfully improved treatment access and outcomes with medications like buprenorphine and behavioral supports, and this work builds on those proven approaches while testing new delivery methods.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Korthuis, Philip Todd — Oregon Health & Science University
- Study coordinator: Korthuis, Philip Todd
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.